Shield Therapeutics
Pre-clinicalDevelops and commercializes pharmaceutical products for iron deficiency and related conditions.
Founded
2008
Focus
Small Molecules
About
Develops and commercializes pharmaceutical products for iron deficiency and related conditions.
Funding History
2Total raised: $80M
PIPE$30MUndisclosedMar 15, 2020
IPO$50MUndisclosedJul 15, 2016
Company Info
TypePrivate
Founded2008
LocationZug, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile